Dual showed no clear difference in myocardial infarction compared with one antiplatelet agent (high certainty).
Multiple showed no clear difference in myocardial infarction compared with fewer antiplatelet agents (high certainty).
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in myocardial infarction compared with placebo or no treatment (high certainty).
The review found no eligible studies for this question.
GLP‐1RA showed no clear difference in myocardial infarction (fatal or non‐fatal) compared with placebo (moderate certainty).
DPP4i showed no clear difference in myocardial infarction (fatal or non‐fatal) compared with placebo (high certainty).
SGLT2i showed no clear difference in myocardial infarction (fatal or non‐fatal) compared with placebo (high certainty).
Dual probably leads to lower stroke, myocardial infarction, or vascular death compared with one antiplatelet agent (moderate certainty).
Multiple probably leads to lower stroke, myocardial infarction, or vascular death compared with fewer antiplatelet agents (moderate certainty).
Local anaesthesia showed no clear difference in myocardial infarction within 30 days of operation compared with general anaesthesia (low certainty).
Carotid artery stenting leads to higher death or any stroke or myocardial infarction between randomisation… compared with endarterectomy (high certainty).
Carotid artery stenting showed no clear difference in death or any stroke or myocardial infarction between randomisation… compared with endarterectomy (moderate certainty).
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in major vascular event (composite of non‐fatal stroke, non‐fatal… compared with placebo or no treatment (high certainty).